After-Hours Stock Movers 12/06: (ACAD) (MDB) (DWAC) Higher; (HQY) (OWL) (SI) Lower (more...)

Blue Owl Capital (OWL) Prices 26.7M Share Secondary Offering at $14.50/sh

Blue Owl Capital Inc. (NYSE: OWL) today announced the pricing of the previously announced underwritten secondary offering by NBSH Blue Investments II, LLC of 26,717,377 shares of the Company's Class A common stock at a price to the public of $14.50 per share. The Offering is expected to close on or about December 9, 2021, subject to the satisfaction of customary closing conditions. In addition, the Selling Stockholder has granted the underwriters a 25-day option to purchase up to an additional 4,007,606 shares of Class A common stock at the public offering price, less underwriting discounts. The Selling... More

Raymond James Downgrades HealthEquity, Inc (HQY) to Outperform

Raymond James analyst C. Gregory Peters downgraded HealthEquity, Inc (NASDAQ: HQY) from Strong Buy to Outperform with a price target of $70.00 (from $90.00) following results.

The analyst commented, "The stock was down over 20% after hours last night as management lowered guidance (see page 2 for changes in guidance) for FY22 due in part to disappointing Service and Interchange revenue results. Service revenue declined 1.7% y/y to $103M in... More

MongoDB (MDB) PT Raised to $550 at Stifel

Stifel analyst Brad Reback raised the price target on MongoDB (NASDAQ: MDB) to $550.00 (from $495.00) while maintaining a Buy rating following results.

The analyst commented, "Mongo beat across all metrics, as Atlas reached >$500M revenue run rate, with the 84% Y/Y growth accelerating... More

Acadia Pharmaceuticals (ACAD) PT Raised to $26 at Mizuho Securities

Mizuho Securities analyst Vamil Divan raised the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $26.00 (from $24.00) while maintaining a Neutral rating.

The analyst commented, "Acadia has released top-line data for their pipeline asset trofinetide for the treatment of Rett syndrome. While... More

MongoDB (MDB) PT Raised to $545 at Goldman Sachs

Goldman Sachs analyst Kash Rangan raised the price target on MongoDB (NASDAQ: MDB) to $545.00 (from $475.00) while maintaining a Buy rating following strong results.

The analyst commented, "Following strong 3Q results from SNOW and DDOG, we continue to see broad based cloud momentum across... More

Acadia’s (ACAD) Rett Syndrome Data Adequate for Approval, Stock Gains Are Justified - Analyst

On December 6th, after market closed, Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced positive top-line results from the pivotal, Phase 3 Lavender study evaluating the efficacy and safety of trofinetide in 187 girls and young women aged 5-20 years with Rett syndrome.Acadia Pharma (NASDAQ: ACAD)

The... More

Silvergate Capital (SI) Prices 3.31M Share Offering at $145/sh

Silvergate Capital Corporation (NYSE: SI) announced today the pricing of an underwritten public offering of 3,310,344 shares of Class A common stock at a price to the public of $145.00 per share. The Company also granted the underwriters a 30-day option to purchase up to an additional 496,551 shares of Class A common stock.

The aggregate gross proceeds of the offering will be approximately $480.0 million before discounts and expenses. Assuming full exercise by the underwriters of their option to purchase additional shares, the aggregate gross proceeds of the offering would be approximately $552.0 million before... More

Gaming and Leisure Properties (GLPI) Prices 7.7M Share Offering at $44.75/sh

Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) today announced that its previously announced underwritten public offering to sell 7,700,000 shares of common stock has been priced for total gross proceeds of approximately $344.6 million. The underwriters will sell the shares to purchasers directly or through agents, through brokers in brokerage transactions on Nasdaq, to dealers in negotiated transactions or in a combination of such methods of sale, at a fixed price or prices, which may be changed, or at market prices prevailing at the time of sale, at prices related to such prevailing market prices... More